Beijing Hotgen Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 116.12 million compared to CNY 202.94 million a year ago. Revenue was CNY 116.12 million compared to CNY 202.94 million a year ago.

Net income was CNY 5.05 million compared to CNY 58.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.06 compared to CNY 0.66 a year ago. Diluted earnings per share from continuing operations was CNY 0.06 compared to CNY 0.66 a year ago.